DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02852694 (ClinicalTrials.gov)	February 28, 2017	9/6/2016	Reduce Risk for Crohn's Disease Patients	Risk-stratified Randomized Controlled Trial in Paediatric Crohn Disease:Methotrexate vs Azathioprine or Adalimumab for Maintaining Remission in Patients at Low or High Risk for Aggressive Disease Course, respectively-a Treatment Strategy	Crohn's Disease	Drug: Methotrexate;Drug: Adalimumab;Drug: Azathioprine / 6 Mercaptopurine	PIBD-Net	European Commission	Recruiting	6 Years	17 Years	All	312	Phase 4	France

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02852694
(ClinicalTrials.gov)

February 28, 2017

9/6/2016

Reduce Risk for Crohn's Disease Patients

Risk-stratified Randomized Controlled Trial in Paediatric Crohn Disease:Methotrexate vs Azathioprine or Adalimumab for Maintaining Remission in Patients at Low or High Risk for Aggressive Disease Course, respectively-a Treatment Strategy

Crohn's Disease

Drug: Methotrexate;Drug: Adalimumab;Drug: Azathioprine / 6 Mercaptopurine

PIBD-Net

European Commission

Recruiting

6 Years

17 Years

All

312

Phase 4

France